This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neuro-otology  • Genetics of Head & Neck Disease  • Hearing Loss/ Deafness  • Pediatric Otolaryngology  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Issues to Consider

Christina G. S. Palmer, PhD; Ariadna Martinez, MS; Yvonne Sininger, PhD; Nina Shapiro, MD; Wayne W. Grody, MD, PhD; Lisa A. Schimmenti, MD

Arch Otolaryngol Head Neck Surg. 2005;131(11):1020-1022.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Newborn hearing screening is currently being implemented in the United States and other countries, allowing early identification of and intervention for hearing loss in neonates. Also, genetic testing is clinically available for the GJB2 gene, which codes for the connexin 26 protein, and the results have begun to explain the cause of a significant number of cases of hearing loss. However, the current limited knowledge about the natural history of GJB2-related hearing loss in the postnatal period, particularly as it relates to age at diagnosis of the hearing loss, raises important clinical and ethical questions that need to be addressed regarding the evaluation of prelingual siblings of children identified with GJB2-related hearing loss.

Approximately 50% of prelingual hearing loss has a genetic basis and approximately . . . [Full Text of this Article]

AUTHOR INFORMATION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?